CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
Bexte, Tobias, Albinger, Nawid, Al Ajami, Ahmad, Wendel, Philipp, Buchinger, Leon, Gessner, Alec, Alzubi, Jamal, Särchen, Vinzenz, Vogler, Meike, Rasheed, Hadeer Mohamed, Jung, Beate Anahita, Wolf, Sebastian, Bhayadia, Raj, Oellerich, Thomas, Klusmann, Jan-Henning, Penack, Olaf, Möker, Nina, Cathomen, Toni, Rieger, Michael A., Imkeller, Katharina, Ullrich, Evelyn
Published in Nature communications (30.09.2024)
Published in Nature communications (30.09.2024)
Get full text
Journal Article
P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI‐LEUKEMIC EFFICACY OF PRIMARY CD33‐TARGETING CAR‐NK CELLS
Albinger, Nawid, Bexte, Tobias, Al‐Ajami, Ahmad, Wendel, Philipp, Buchinger, Leon, Gessner, Alec, Alzubi, Jamal, Särchen, Vinzenz, Vogler, Meike, Bhayadia, Raj, Klusmann, Jan‐Henning, Möker, Nina, Cathomen, Toni, Rieger, Michael A., Imkeller, Katharina, Ullrich, Evelyn
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Unleashing the power of NK cells in anticancer immunotherapy
Vogler, Meike, Shanmugalingam, Senthan, Särchen, Vinzenz, Reindl, Lisa Marie, Grèze, Victoria, Buchinger, Leon, Kühn, Michael, Ullrich, Evelyn
Published in Journal of molecular medicine (Berlin, Germany) (01.03.2022)
Published in Journal of molecular medicine (Berlin, Germany) (01.03.2022)
Get full text
Journal Article
CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML
Albinger, Nawid, Bexte, Tobias, Buchinger, Leon, Wendel, Philipp, Al-Ajami, Ahmad, Gessner, Alec, Särchen, Vinzenz, Alzubi, Jamal, Mertlitz, Sarah, Penack, Olaf, Bhayadia, Raj, Klusmann, Jan-Henning, Vogler, Meike, Möker, Nina, Cathomen, Toni, Rieger, Michael A., Imkeller, Katharina, Ullrich, Evelyn
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective on CAR-NK Cell Therapy
Gierschek, Fenja, Schlueter, Juliane, Kühnel, Ines, Feigl, Frederik Fabian, Schmiedel, Dominik, Prüfer, Maren, Buchinger, Leon, Cerwenka, Adelheid, Cappel, Claudia, Huenecke, Sabine, Köhl, Ulrike, Wels, Winfried S., Ullrich, Evelyn
Published in Transfusion medicine and hemotherapy (01.10.2024)
Published in Transfusion medicine and hemotherapy (01.10.2024)
Get full text
Journal Article